Solubility Advantage of Pharmaceutical Cocrystals
By D. Good, N. Rodríguez-Hornedo. 2009
779 citations recorded by the source corpus.
Subfields: Materials Chemistry, Molecular Biology, Physical and Theoretical Chemistry
View Paper: https://www.semanticscholar.org/paper/efe02e9b35be6381d17307b6ee443945112610ca
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Materials Chemistry
- Christopher J. H. Porter
- W. Charman
- S. Charman
- H. Williams
- R. Shanker
- Natalie L. Trevaskis
- Colin W. Pouton
In Molecular Biology
- W. Charman
- Colin W. Pouton
- Christopher J. H. Porter
- S. Charman
- H. Williams
- R. Shanker
- Natalie L. Trevaskis
Citations in the corpus
- Strategies to Address Low Drug Solubility in Discovery and Development (2013, methodology): “…obtained for a series of cocrystals of carbamazepine, theophylline, and caffeine suggest that coformer solubility values must be at least 10-fold higher than drug solubility to generate cocrystals with improved solubility greater than that of crystalline drug (Good and Rodriguez-Hornedo, 2009).”